SDC1 and Miyoshi myopathy: 3 immunocytokines combining the specificity of IgG1 anti-CD138 mAb with the cytokines IFNα14, IFNα2 or IFNα2YNS, a mutated moiety, were investigated regarding their use as a therapeutic approach in MM.